APOE and Alzheimer disease: Gupta et al. [16] proposed a machine-learning-based framework to distinguish subjects with AD from those with MCI by using four different biomarkers: sMRI, the apolipoprotein E (APOE) genotype, cerebrospinal fluid (CSF) protein level, and FDG-PET from the ADNI dataset.